Results per Page:
Revaccination beliefs and behaviors in transplant survivors
From the UW School of Nursing in collaboration with the Long-Term Follow-Up Program, Clinical Research Division
Mutations remain one-in-a-million after HCT
From the Storb Group, Clinical Research Division
A charming model: new tool evaluates risk of transplant for older patients
Seven values are evaluated to predict outcomes
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
Calculating the risk: Lower respiratory tract infection in transplant recipients
From the Boeckh Lab, Clinical Research and Vaccine and Infectious Disease Divisions
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Dr. Stanley Riddell awarded Burke O'Reilly Family Endowed Chair in Immunotherapy
Inspired by child's life-threatening illness, family's gift funds development of next-gen therapies
Harnessing the power of genetics to improve transplant safety
From the Petersdorf Group, Clinical Research Division
Common cold can be surprisingly dangerous for transplant patients
Study shows typically ‘mild’ respiratory virus can turn into deadly pneumonia in this vulnerable population, points to need for effective meds, better prevention
Fred Hutchinson Cancer Research Center Investigator Find that Transplant Patients' Newly-Developed Immune Systems Function Effectively 20 to 30 Years Later
Participating in the study were the world's longest transplant survivors who are living healthy and active lives